Opioids and the Risk of Infection: A Critical Appraisal of the Pharmacologic and Clinical Evidence

References

• Hastie BA, Gilson AM, Maurer MA, et al. An examination of global and regional opioid consumption trends 1980–2011. J Pain Palliat Care Pharmacother. 2014 Sep;28(3):259–275.
   Google Scholar
• Guy GP Jr., Zhang K, Bohm MK, et al. Vital signs: changes in opioid prescribing in the United States, 2006–2015. MMWR Morb Mortal Wkly Rep. 2017 Jul 7;66(26):697–704.
   Google Scholar
• Schuchat A, Houry D, Guy GP Jr. New data on opioid use and prescribing in the United States. JAMA. 2017 Aug 1;318(5):425–426.
   Google Scholar
• Seth P, Rudd RA, Noonan RK, et al. Quantifying the epidemic of prescription opioid overdose deaths. Am J Public Health. 2018 Apr;108(4):500–502.
   Google Scholar
• Kroenke K, Cheville A. Management of chronic pain in the aftermath of the opioid backlash. JAMA. 2017 Jun 20;317(23):2365–2366.
   Google Scholar
• Chou R, GJ F, PG F, et al. Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain. J Pain. 2009 Feb;10(2):113–130.
   Google Scholar
• Chou R, Turner JA, Devine EB, et al. The effectiveness and risks of long-term opioid therapy for chronic pain: a systematic review for a National Institutes of Health Pathways to Prevention Workshop. Ann Intern Med. 2015 Feb 17;162(4):276–286.
   Google Scholar
• Vuong C, Van Uum SH, O’Dell LE, et al. The effects of opioids and opioid analogs on animal and human endocrine systems. Endocr Rev. 2010 Feb;31(1):98–132.
   Google Scholar
• Krebs EE, Gravely A, Nugent S, et al. Effect of opioid vs nonopioid medications on pain-related function in patients with chronic back pain or hip or knee osteoarthritis pain: the SPACE randomized clinical trial. JAMA. 2018 Mar 6;319(9):872–882.
   Google Scholar
• Harned M, Sloan P. Safety concerns with long-term opioid use. Expert Opin Drug Saf. 2016 Jul;15(7):955–962.
   Google Scholar
• Seyfried O, Hester J. Opioids and endocrine dysfunction. Br J Pain. 2012 Feb;6(1):17–24.
   Google Scholar
• Boland JW, Pockley AG. Influence of opioids on immune function in patients with cancer pain: from bench to bedside. Br J Pharmacol. 2018 Jul;175(14):2726–2736.
   Google Scholar
• Liang X, Liu R, Chen C, et al. Opioid system modulates the immune function: a review. Transl Perioper Pain Med. 2016;1(1):5–13.
   Google Scholar
• Dublin S, Walker RL, Jackson ML, et al. Use of opioids or benzodiazepines and risk of pneumonia in older adults: a population-based case-control study. J Am Geriatr Soc. 2011 Oct;59(10):1899–1907.
   Google Scholar
• Edelman EJ, Gordon KS, Crothers K, et al. Association of prescribed opioids with increased risk of community-acquired pneumonia among patients with and without HIV. JAMA Intern Med. 2019 Jan 7.
   Google Scholar
• Wiese AD, Griffin MR, Stein CM, et al. Opioid analgesics and the risk of serious infections among patients with rheumatoid arthritis: a self-controlled case series study. Arthritis Rheumatol. 2016 Feb;68(2):323–331.
   Google Scholar
• Wiese AD, Griffin MR, Schaffner W, et al. Opioid analgesic use and risk for invasive pneumococcal diseases: a nested case-control study. Ann Intern Med. 2018 Mar 20;168(6):396–404.
   Google Scholar
• Wiese AD, Griffin MR, Schaffner W, et al. Long-acting opioid use and the risk of serious infections: a retrospective cohort study. Clin Infect Dis. 2019 May 17;68(11):1862-1869.
   Google Scholar
• Schwacha MG, McGwin G Jr., Hutchinson CB, et al. The contribution of opiate analgesics to the development of infectious complications in burn patients. Am J Surg. 2006 Jul;192(1):82–86.
   Google Scholar
• Suzuki M, Sakurada T, Gotoh K, et al. Correlation between the administration of morphine or oxycodone and the development of infections in patients with cancer pain. Am J Hosp Palliat Care. 2013 Nov;30(7):712–716.
   Google Scholar
• Mora AL, Salazar M, Pablo-Caeiro J, et al. Moderate to high use of opioid analgesics are associated with an increased risk of clostridium difficile infection. Am J Med Sci. 2012 Apr;343(4):277–280.
   Google Scholar
• Vozoris NT, Wang X, Fischer HD, et al. Incident opioid drug use and adverse respiratory outcomes among older adults with COPD. Eur Respir J. 2016 Sep;48(3):683–693.
   Google Scholar
• Brack A, Rittner HL, Stein C. Immunosuppressive effects of opioids–clinical relevance. J Neuroimmune Pharmacol. 2011 Dec;6(4):490–502.
   Google Scholar
• Holden JE, Jeong Y, Forrest JM. The endogenous opioid system and clinical pain management. AACN Clin Issues. 2005 Jul Sep;16(3):291–301.
   Google Scholar
• Drewes AM, Jensen RD, Nielsen LM, et al. Differences between opioids: pharmacological, experimental, clinical and economical perspectives. Br J Clin Pharmacol. 2013 Jan;75(1):60–78.
   Google Scholar
• Ebert B, Thorkildsen C, Andersen S, et al. Opioid analgesics as noncompetitive N-methyl-D-aspartate (NMDA) antagonists. Biochem Pharmacol. 1998 Sep 1;56(5):553–559.
   Google Scholar
• Xie N, Gomes FP, Deora V, et al. . Activation of mu-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice. Brain Behav Immun. 2017;61:244–258.
   Google Scholar
• Bidlack JM, Khimich M, Parkhill AL, et al. Opioid receptors and signaling on cells from the immune system. J Neuroimmune Pharmacol. 2006 Sep;1(3):260–269.
   Google Scholar
• Saurer TB, Carrigan KA, Ijames SG, et al. Suppression of natural killer cell activity by morphine is mediated by the nucleus accumbens shell. J Neuroimmunol. 2006 Apr;173(1–2):3–11.
   Google Scholar
• Sacerdote P. Opioid-induced immunosuppression. Curr Opin Support Palliat Care. 2008 Mar;2(1):14–18.
   Google Scholar
• Jacobs R, Karst M, Scheinichen D, et al. Effects of fentanyl on cellular immune functions in man. Int J Immunopharmacol. 1999 Jul;21(7):445–454.
   Google Scholar
• Liu Z, Gao F, Tian Y. Effects of morphine, fentanyl and tramadol on human immune response. J Huazhong Univ Sci Technolog Med Sci. 2006;26(4):478–481.
   Google Scholar
• Rodriguez-Vita J, Lawrence T. The resolution of inflammation and cancer. Cytokine Growth Factor Rev. 2010 Feb;21(1):61–65.
   Google Scholar
• Roy S, Wang J, Kelschenbach J, et al. Modulation of immune function by morphine: implications for susceptibility to infection. J Neuroimmune Pharmacol. 2006 Mar;1(1):77–89.
   Google Scholar
• Sacerdote P, Manfredi B, Mantegazza P, et al. Antinociceptive and immunosuppressive effects of opiate drugs: a structure-related activity study. Br J Pharmacol. 1997 Jun;121(4):834–840.
   Google Scholar
• Plein LM, Rittner HL. Opioids and the immune system - friend or foe. Br J Pharmacol. 2018 Jul;175(14):2717-2725.
   Google Scholar
• Hsueh CM, Chen SF, Huang HJ, et al. Activation of mu-opioid receptors are required for the conditioned enhancement of NK cell activity. Brain Res. 1996 Oct 21;737(1–2):263–268.
   Google Scholar
• Yokota T, Uehara K, Nomoto Y. Addition of noradrenaline to intrathecal morphine augments the postoperative suppression of natural killer cell activity. J Anesth. 2004;18(3):190–195.
   Google Scholar
• Borman A, Ciepielewski Z, Wrona D, et al. Small doses of morphine can enhance NK cell cytotoxicity in pigs. Int Immunopharmacol. 2009 Mar;9(3):277–283.
   Google Scholar
• Gomez-Flores R, Weber RJ. Differential effects of buprenorphine and morphine on immune and neuroendocrine functions following acute administration in the rat mesencephalon periaqueductal gray. Immunopharmacology. 2000 Jul 20;48(2):145–156.
   Google Scholar
• House RV, Thomas PT, Bhargava HN. In vitro evaluation of fentanyl and meperidine for immunomodulatory activity. Immunol Lett. 1995 May;46(1–2):117–124.
   Google Scholar
• Sacerdote P, Bianchi M, Gaspani L, et al. The effects of tramadol and morphine on immune responses and pain after surgery in cancer patients. Anesth Analg. 2000 Jun;90(6):1411–1414.
   Google Scholar
• Beilin B, Grinevich G, Yardeni IZ, et al. Tramadol does not impair the phagocytic capacity of human peripheral blood cells. Can J Anaesth. 2005 December 1;52(10):1035–1039.
   Google Scholar
• Gong L, Qin Q, Zhou L, et al. Effects of fentanyl anesthesia and sufentanil anesthesia on regulatory T cells frequencies. Int J Clin Exp Pathol. 2014;7(11):7708–7716.
   Google Scholar
• Ma K, Ma P, Lu H, et al. Fentanyl suppresses the survival of CD4(+) T cells isolated from human umbilical cord blood through inhibition of IKKs-mediated NF-kappaB activation. Scand J Immunol. 2017 May;85(5):343–349.
   Google Scholar
• House RV, Thomas PT, Bhargava HN. In vitro evaluation of fentanyl and meperidine for immunomodulatory activity. Immunol Lett. 1995 May 01;46(1):117–124.
   Google Scholar
• Breslow JM, Monroy MA, Daly JM, et al. Morphine, but not trauma, sensitizes to systemic acinetobacter baumannii infection. J Neuroimmune Pharmacol. 2011 Dec;6(4):551–565.
   Google Scholar
• Singhal PC, Kapasi AA, Franki N, et al. Morphine-induced macrophage apoptosis: the role of transforming growth factor-beta. Immunology. 2000 May;100(1):57–62.
   Google Scholar
• Bhaskaran M, Reddy K, Sharma S, et al. Morphine-induced degradation of the host defense barrier: role of macrophage injury. J Infect Dis. 2001 Dec 15;184(12):1524–1531.
   Google Scholar
• Bencsics A, Elenkov IJ, Vizi ES. Effect of morphine on lipopolysaccharide-induced tumor necrosis factor-alpha production in vivo: involvement of the sympathetic nervous system. J Neuroimmunol. 1997 Mar;73(1–2):1–6.
   Google Scholar
• Roy S, Cain KJ, Chapin RB, et al. Morphine modulates NF kappa B activation in macrophages. Biochem Biophys Res Commun. 1998 Apr 17;245(2):392–396.
   Google Scholar
• Singh PP, Singal P. Morphine-induced neuroimmunomodulation in murine visceral leishmaniasis: the role(s) of cytokines and nitric oxide. J Neuroimmune Pharmacol. 2007 Dec;2(4):338–351.
   Google Scholar
• Makarenkova VP, Esche C, Kost NV, et al. Identification of delta- and mu-type opioid receptors on human and murine dendritic cells. J Neuroimmunol. 2001 Jul 2;117(1–2):68–77.
   Google Scholar
• Wang J, Ma J, Charboneau R, et al. Morphine inhibits murine dendritic cell IL-23 production by modulating Toll-like receptor 2 and Nod2 signaling. J Biol Chem. 2011 Mar 25;286(12):10225–10232.
   Google Scholar
• Campana G, Sarti D, Spampinato S, et al. Long-term intrathecal morphine and bupivacaine upregulate MOR gene expression in lymphocytes. Int Immunopharmacol. 2010 Sep;10(9):1149–1152.
   Google Scholar
• Zhang EY, Xiong J, Parker BL, et al. Depletion and recovery of lymphoid subsets following morphine administration. Br J Pharmacol. 2011 Dec;164(7):1829–1844.
   Google Scholar
• Carpenter GW, Breeden L, Carr DJ. Acute exposure to morphine suppresses cytotoxic T-lymphocyte activity. Int J Immunopharmacol. 1995 Dec;17(12):1001–1006.
   Google Scholar
• Carpenter GW, Garza HH Jr., Gebhardt BM, et al. Chronic morphine treatment suppresses CTL-mediated cytolysis, granulation, and cAMP responses to alloantigen. Brain Behav Immun. 1994 Sep;8(3):185–203.
   Google Scholar
• Brown JN, Ortiz GM, Angel TE, et al. Morphine produces immunosuppressive effects in nonhuman primates at the proteomic and cellular levels. Mol Cell Proteomics. 2012 Sep;11(9):605–618.
   Google Scholar
• Beagles K, Wellstein A, Bayer B. Systemic morphine administration suppresses genes involved in antigen presentation. Mol Pharmacol. 2004 Feb;65(2):437–442.
   Google Scholar
• Oppong E, Cato AC. Effects of glucocorticoids in the immune system. Adv Exp Med Biol. 2015;872:217–233.
   Google Scholar
• El Daly ES. Influence of acute and chronic morphine or stadol on the secretion of adrenocorticotrophin and its hypothalamic releasing hormone in the rat. Life Sci. 1996;59(22):1881–1890.
   Google Scholar
• Allolio B, Schulte HM, Deuss U, et al. Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone. Acta Endocrinol. 1987 Apr;114(4):509–514.
   Google Scholar
• Gibb FW, Stewart A, Walker BR, et al. Adrenal insufficiency in patients on long-term opioid analgesia. Clin Endocrinol. 2016 Dec;85(6):831–835.
   Google Scholar
• Tsagarakis S, Rees LH, Besser M, et al. Opiate receptor subtype regulation of CRF-41 release from rat hypothalamus in vitro. Neuroendocrinology. 1990 May;51(5):599–605.
   Google Scholar
• Tsagarakis S, Navarra P, Rees LH, et al. Morphine directly modulates the release of stimulated corticotrophin-releasing factor-41 from rat hypothalamus in vitro. Endocrinology. 1989 May;124(5):2330–2335.
   Google Scholar
• Fecho K, Maslonek KA, Dykstra LA, et al. Evidence for sympathetic and adrenal involvement in the immunomodulatory effects of acute morphine treatment in rats. J Pharmacol Exp Ther. 1996 May;277(2):633–645.
   Google Scholar
• Chaney MA. Side effects of intrathecal and epidural opioids. Can J Anaesth. 1995 Oct;42(10):891–903.
   Google Scholar
• Dahan MDPDA, Aarts MDPDL, Smith PDTerry W. Incidence, reversal, and prevention of opioid-induced respiratory depression. Anesthesiology. 2010;112(1):226–238.
   Google Scholar
• Pattinson KTS. Opioids and the control of respiration. Br J Anaesth. 2008;100(6):747–758.
   Google Scholar
• Whang BY, Jeong SW, Leem JG, et al. Aspiration pneumonitis caused by delayed respiratory depression following intrathecal morphine administration. Korean J Pain. 2012;25(2):126–129.
   Google Scholar
• Horwitz RI, Feinstein AR. The problem of “protopathic bias” in case-control studies. Am J Med. 1980 Feb;68(2):255–258.
   Google Scholar
• Tamim H, Monfared AA, LeLorier J. Application of lag-time into exposure definitions to control for protopathic bias. Pharmacoepidemiol Drug Saf. 2007 Mar;16(3):250–258.
   Google Scholar
• Kyriacou DN, Lewis RJ. Confounding by indication in Clinical Research. JAMA. 2016 Nov 1;316(17):1818–1819.
   Google Scholar
• Petersen I, Douglas I, Whitaker H. Self controlled case series methods: an alternative to standard epidemiological study designs. BMJ. 2016 Sep 12;354:i4515.
   Google Scholar
• Whitaker HJ, Ghebremichael-Weldeselassie Y, Douglas IJ, et al. Investigating the assumptions of the self-controlled case series method. Stat Med. 2018 Feb 20;37(4):643–658.
   Google Scholar
• Maclure M. The case-crossover design: a method for studying transient effects on the risk of acute events. Am J Epidemiol. 1991 Jan 15;133(2):144–153.
   Google Scholar
• Hallas J, Pottegard A, Wang S, et al. Persistent user bias in case-crossover studies in pharmacoepidemiology. Am J Epidemiol. 2016 Nov 15;184(10):761–769.
   Google Scholar
• Lund JL, Richardson DB, Sturmer T. The active comparator, new user study design in pharmacoepidemiology: historical foundations and contemporary application. Curr Epidemiol Rep. 2015 Dec;2(4):221–228.
   Google Scholar
• Shao YJ, Liu WS, Guan BQ, et al. Contribution of opiate analgesics to the development of infections in advanced cancer patients. Clin J Pain. 2017 Apr;33(4):295–299.
   Google Scholar
• Jeffery MM, Hooten WM, Henk HJ, et al. Trends in opioid use in commercially insured and medicare advantage populations in 2007–16: retrospective cohort study. BMJ. 2018 Aug 1;362:k2833.
   Google Scholar
• Borgundvaag B, McLeod S, Khuu W, et al. Opioid prescribing and adverse events in opioid-naive patients treated by emergency physicians versus family physicians: a population-based cohort study. CMAJ Open. 2018 Mar 1;6(1):E110–E117.
   Google Scholar